SEC Company Response from Fortress Biotech, Inc. (FBIO, FBIOP) (CIK 0001429260) (FBIO) — Jul 20, 2018
Fortress Biotech, Inc. (FBIO, FBIOP) (CIK 0001429260)
Date: July 20, 2018 · CIK: 0001429260 · Accession: 0001144204-18-039151
AI Filing Summary & Sentiment
Show Raw Text
CORRESP
1
filename1.htm
90 Park Avenue
New York, NY 10016
212-210-9400
Fax: 212-922-3995
www.alston.com
Mark F. McElreath
Direct Dial: 212-210-9595
Email: mark.mcelreath@alston.com
July 20, 2018
VIA: UNITED PARCEL SERVICE
Mr. Jeffrey Gabor
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re:
Fortress Biotech, Inc.
Registration Statement on Form S-3
Filed July 6, 2018
File No. 333- 226089
Dear Mr. Gabor:
On behalf
of Fortress Biotech, Inc., a Delaware corporation (the “Company”), we hereby respond to the Commission’s
comment telephone call on July 12, 2018 relating to the Company’s Registration Statement on Form S-3 filed on July
6, 2018.
Comment:
We note that the Company needs to file a Form of Indenture as
Exhibit 4.5 to the Company’s Registration Statement on Form S-3.
Response:
The Company has filed an amended Form S-3 with a Form of Indenture,
filed as Exhibit 4.5 to the Company’s Registration Statement on Form S-3 filed on July 6, 2018.
Sincerely,
ALSTON & BIRD LLP
By:
/s/ Mark F. McElreath
Mark F. McElreath
Partner
Atlanta •
Brussels • Charlotte • Dallas • Los Angeles • New York • Research Triangle • Silicon Valley •
Ventura County • Washington, D.C.